SCHEMBL5950574

SCHEMBL5950574

O=C(O)C(CNC(=O)N1CCC2(CC1)C(=O)NCN2c1ccccc1)NC(=O)[C@@H]1CCC(=O)N1Cc1ccccc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ITGB1 P05556 7/20 0.49
ITGA4 P13612 7/20 0.49
OPRK1 P41145 5/20 0.48
OPRM1 P35372 2/20 0.47
OPRL1 P41146 2/20 0.47
OPRD1 P41143 1/20 0.47
HTR2C P28335 2/20 0.45
DRD3 P35462 1/20 0.45
AVPR1A P37288 1/20 0.45
PLD2 O14939 1/20 0.44
PLD1 Q13393 1/20 0.44
CCR3 P51677 1/20 0.44
HTR1A P08908 1/20 0.43
ADORA3 P0DMS8 1/20 0.43
SLC6A3 Q01959 1/20 0.43
CTSB P07858 1/20 0.43
CTSS P25774 1/20 0.43
CTSK P43235 1/20 0.43
CAPN1 P07384 1/20 0.43
CALCRL Q16602 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5950389 0.94 OPRK1 (0.46) ITGB1ITGA4OPRK1OPRM1OPRL1
SCHEMBL5950534 0.86 ITGB1 (0.49) ITGB1ITGA4OPRL1CCR3CAPN1
SCHEMBL5780094 0.83 CTSB (0.58) OPRK1OPRM1OPRL1OPRD1PLD2
SCHEMBL5950640 0.82 OPRK1 (0.47) OPRK1OPRM1OPRL1OPRD1PLD2
SCHEMBL5950573 0.81 OPRK1 (0.47) OPRK1OPRM1OPRL1OPRD1PLD2
SCHEMBL5950410 0.81 ITGB1 (0.45) ITGB1ITGA4OPRK1OPRM1OPRL1
SCHEMBL5950215 0.80 OPRK1 (0.53) OPRK1OPRM1OPRL1OPRD1HTR2C
SCHEMBL6481140 0.80 OPRK1 (0.52) OPRK1OPRM1OPRL1OPRD1HTR2C
SCHEMBL5780364 0.80 OPRK1 (0.49) OPRK1OPRM1OPRL1OPRD1HTR2C
SCHEMBL5950194 0.78 OPRK1 (0.46) OPRK1OPRM1OPRL1OPRD1HTR2C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20060241132-A1 Spiro derivatives and adhesion molecule inhibitors comprising the same as active ingredient TORAY INDUSTRIES, INC. A CORPORATION OF JAPAN (JP) 2006-10-26 US disclosed
EP-1489081-A1 SPIRO DERIVATIVES AND ADHESION MOLECULE INHIBITORS COMPRISING THE SAME AS THE ACTIVE INGREDIENT TORAY INDUSTRIES, INC. (JP) 2004-12-22 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060241132-A1 Spiro derivatives and adhesion molecule inhibitors comprising the same as active ingredient VCAM1, SELL, ICAM1 ITGB1 14/4885ITGA4 6/4885OPRK1 2459/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.